ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 30706 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 30706; 2) Community: the network communities that were significantly associated with the response to NSC 30706; 3) Molecule: the relationships between components within communities and NSC 30706; 4) MDR: the compounds that were significantly associated with the NSC 30706.

NSC Compound Enrichment Correlation
NSC 618939 Camptothecin Derivative 0.000573863872925603 0.61207933
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.000573863872925603 0.45394272
NSC 727354 6-[(4-FMOCamino)-1-butyl]-5,6-dihydro-2,3-dimethoxy-8,9-meth ylenedioxy-5,11-dioxo-11H-indeno[1,2-c-isoquinoline 0.000573863872925603 0.51101949
NSC 735037 Camptothecin Derivative 0.000573863872925603 0.57834902
NSC 98572 .beta.-Resorcylaldehyde, 2-pyridylhydrazone 0.000573863872925603 0.45349767
NSC 726432 Null 0.000588249147782798 0.37229173
NSC 750148 3-(2-Hydroxy-5-chloro-4-methylphenyl)-5-(2-phenylethene)-1-(4-sulfamylphenyl)-pyrazoline 0.000588249147782798 -0.19959286
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.000649370174092106 0.52826436
NSC 261726 ICN 4221 0.000710545569439728 0.36528445
NSC 628949 Null 0.000710545569439728 0.38741169
Total:84  Current:2    [First] [Prev] [Next] [Last]